Propanc Biopharma Inc share price logo

Propanc Biopharma Inc Share Price

NASDAQ: PPCB

Small Cap

$1.77

-0.07

(-3.80%)

as on

Propanc Biopharma Inc Stock Performance

as on October 4, 2025 at 1:23 am IST

  • Day's High

    $1.77
    $1.91

    7.91%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.25
    $30
    downward going graph

    29.38%

    Downside

    1594.92%

    Upside

    downward going graph

Propanc Biopharma Inc share price movements today

Previous Close
$1.84
Open
$1.82
Volume
497.4K
Day's Low - High
$1.77 - $1.91
52 Week Low - High
$1.25 - $30

Propanc Biopharma Inc Historical Returns

1 Month Return
-10.61 %
3 Month Return
-58.35 %
1 Year Return
-88.2 %
3 Year Return
-100 %
5 Year Return
0 %

Propanc Biopharma Inc Stock Fundamentals & Key Indicators

Check Propanc Biopharma Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$23.6M

EPS (TTM)

0

Dividend Yield

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

Return On Equity TTM

4340300.00%

Propanc Biopharma Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Propanc Biopharma Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
NA$23.6MNANA0.00%
NA$40.5BNANA-3.89%
BUY$60.4B236.34%-505.15-12.96%
BUY$104.8B54.64%29.0631.86%
BUY$63.6B6.23%15.1331.37%

Stock Returns calculator for Propanc Biopharma Inc Stock including INR - Dollar returns

The Propanc Biopharma Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Propanc Biopharma Inc investment value today

Current value as on today

₹17,573

Returns

₹82,427

(-82.43%)

Returns from Propanc Biopharma Inc Stock

₹88,200 (-88.2%)

Dollar Returns*

₹5,773 (+5.77%)

Propanc Biopharma Inc Stock’s Investor Sentiment and Interest

Search interest for Propanc Biopharma Inc Stock has decreased by -76% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-76% versus previous 30 day period

Propanc Biopharma Inc Quarterly Profit & Loss

All numbers in Millions USD

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
0
0
0
0
0
0
0
0
0
-53
EBITDA
0
0
0
0
0
0
0
0
0
-53
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
0
0
0
0
0
0
0
0
0
-54
Income Tax Expense
0
0
0
0
0
0
0
-
-
-
Net Income
0
0
0
0
0
0
0
0
0
-54
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Propanc Biopharma Inc Annual Profit & Loss

All numbers in Millions USD

Jun 2016
Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Total Revenue
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
0
0
Operating Income
-6
-5
-3
-2
-3
-1
-1
-1
-1
EBITDA
-4
-4
-4
-4
-3
-1
-2
-2
-1
Interest Expense
4
3
2
1
1
0
0
0
0
Depreciation
-
0
0
0
0
0
0
0
0
Income Before Tax
-9
-8
-7
-5
-4
-2
-2
-2
-1
Income Tax Expense
0
0
0
0
0
0
0
0
0
Net Income
-9
-7
-7
-5
-4
-2
-2
-2
-1
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Propanc Biopharma Inc Quarterly Cash Flow

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Net Income
0
0
0
0
0
0
0
0
-54
Operating Cash Flow
0
0
0
0
0
0
0
0
0
Investing Cash Flow
-
-
-
-
-
-
-
-
-
Financing Cash Flow
0
0
0
0
0
0
0
0
0
Change in Cash
0
0
0
0
0
0
0
0
0

Propanc Biopharma Inc Annual Cash Flow

All numbers in Millions USD

Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Net Income
-7
-7
-5
-4
-2
-2
-2
-1
-58
Operating Cash Flow
-2
-2
-2
-1
-1
-1
-1
0
0
Investing Cash Flow
0
0
0
-
-
-
-
-
-
Financing Cash Flow
2
2
2
1
1
1
1
0
0
Change in Cash
0
0
0
0
0
0
0
0
0

Insights on Propanc Biopharma Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Beone Medicines Ltd has given 127.8% return, outperforming this stock by 227.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 67.9% return, outperforming this stock by 158.5%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, PPCB stock has moved down by -6.1%

About Propanc Biopharma Inc

Propanc Biopharma, Inc. is an Australia-based clinical biopharmaceutical company. The Company is focused on the development of novel cancer treatments for patients suffering from pancreatic, ovarian and colorectal cancers. The Company has developed a rational, composite formulation of anti-cancer compounds, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its lead product candidate, PRP, is a variation upon its formulation and involves pro-enzymes, the inactive precursors of enzymes. PRP is a long-term therapy based on a pancreatic proenzyme formulation to prevent tumor recurrence and metastasis. PRP is a patented, formulation consisting of two proenzymes mixed in a synergetic ratio. PRP is in the preclinical phase of development. Its drug pipeline also includes POP1.
OrganisationPropanc Biopharma Inc
Headquarters302, 6 Butler Street, Camberwell, VIC, Australia, 3124
CEOMr. James Nathanielsz
E-voting on sharesClick here to vote

Key Management of Propanc Biopharma Inc

Name

Title

Mr. James Nathanielsz

CEO & Executive Chairman

Dr. Julian Norman Kenyon ChB, M.D., MB

Chief Scientific Officer & Director

Ms. Jeannine Zimmerman

Chief Financial Officer

Prof. Klaus Kutz M.D.

Chief Medical Officer & Member of Scientific Advisory Board

FAQs

What is Propanc Biopharma Inc share price today?

Propanc Biopharma Inc share price today is $1.77 as on at the close of the market. Propanc Biopharma Inc share today touched a day high of $1.91 and a low of $1.77.

What is the 52 week high and 52 week low for Propanc Biopharma Inc share?

Propanc Biopharma Inc share touched a 52 week high of $30 on and a 52 week low of $1.25 on . Propanc Biopharma Inc stock price today i.e. is closed at $1.77,which is 94.10% down from its 52 week high and 41.60% up from its 52 week low.

What is Propanc Biopharma Inc's market capitalisation today?

Propanc Biopharma Inc market capitalisation is $0.00T as on .

How to invest in Propanc Biopharma Inc Stock (PPCB) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Propanc Biopharma Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Propanc Biopharma Inc Shares that will get you 0.8475 shares as per Propanc Biopharma Inc share price of $1.77 per share as on October 4, 2025 at 1:23 am IST.

What is the minimum amount required to buy Propanc Biopharma Inc Stock (PPCB) from India?

Indian investors can start investing in Propanc Biopharma Inc (PPCB) shares with as little as ₹88.775 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹887.75 in Propanc Biopharma Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Propanc Biopharma Inc share’s latest price of $1.77 as on October 4, 2025 at 1:23 am IST, you will get 5.6497 shares of Propanc Biopharma Inc. Learn more about fractional shares .